New way to treat Lysosomal storage Disorders
Home
About us
History
People
Our science
Partnering
Publications
News
Contact us
September, 2016
Orphan designation was granted by European commission for the recombinant GAA-AMFA developed by NanoMedSyn for the treatment of Pompe’s disease.
EMA (EU/3/16/1726)
Last news
In Memory of our former CEO- November, 2021
October, 2021
July, 2021
June, 2021
December, 2020
About NanoMedSyn
15 Avenue Charles Flahault 34090 Montpellier
contact@nanomedsyn.com